BAIN CAPITAL INVESTORS LLC Long-Term Concentrated

CIK: 0001040508 · Show all filings

Period: Q1 2019 (← Previous) (Next →)

Filing Date: May 15, 2019

Total Value ($000): $2,619,621 (100.0% shares, 0.0% debt)

Holdings (7)

G GENPACT LIMITED 43.0%

Value ($000) $1,127,097 Shares 32,038,002 Est. Cost $17.18 Unrealized +69.5%

— MICHAELS COS INC 23.0%

Value ($000) $602,964 Shares 52,798,929 Est. Cost $17.48 Unrealized —

SGRY SURGERY PARTNERS INC 11.4%

Value ($000) $298,420 Shares 26,455,651 Est. Cost $14.30 Unrealized -11.9%

IQV IQVIA HLDGS INC 11.1%

Value ($000) $289,935 Shares 2,015,534 Est. Cost $101.80 Unrealized +30.9%

— ATENTO S A 6.7%

Value ($000) $175,160 Shares 48,520,671 Est. Cost $10.45 Unrealized —

— VERITIV CORP 2.8%

Value ($000) $73,217 Shares 2,783,840 Est. Cost $50.06 Unrealized —

— FRANKS INTL N V 2.0%

Value ($000) $52,828 Shares 8,506,930 Est. Cost $12.31 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
G	GENPACT LIMITED	32,038,002	$1,127,097	43.0%	$17.18	+69.5%	SHS	G3922B107
—	MICHAELS COS INC	52,798,929	$602,964	23.0%	$17.48	—	COM	59408Q106
SGRY	SURGERY PARTNERS INC	26,455,651	$298,420	11.4%	$14.30	-11.9%	COM	86881A100
IQV	IQVIA HLDGS INC	2,015,534	$289,935	11.1%	$101.80	+30.9%	COM	46266C105
—	ATENTO S A	48,520,671	$175,160	6.7%	$10.45	—	SHS	L0427L105
—	VERITIV CORP	2,783,840	$73,217	2.8%	$50.06	—	COM	923454102
—	FRANKS INTL N V	8,506,930	$52,828	2.0%	$12.31	—	COM	N33462107